INTRODUCTION
Intensive care units have come to represent the most frequently identifiable source of nosocomial infections within the hospital, with the infection rates and rate of antimicrobial resistance several fold greater than the general hospital settings. Ventilator-associated pneumonia (VAP) is defined as nosocomial pneumonia in mechanically ventilated patients that develops more than 48 hours after initiation of mechanical ventilation (MV). VAP is the second most common nosocomial infection after urinary tract infection in pediatric intensive care unit patients accounting for 20% of nosocomial infection in this population
1.
Langer and co-workers divided VAP into early onset VAP which occurs within 5 days of mechanical ventilation and late onset VAP, which develops five or more days after initiation of mechanical ventilation. 2 The importance of segregating VAP into early and late is that, the pathogenesis, microorganisms responsible and outcome in these two groups are different and so the therapeutic implications also differ. Early onset VAP results from aspiration of endogenous community acquired organisms e.g. S. pneumoniae, H. influenzae, and other organisms (aerobic gram negative bacilli). Late onset VAP is more severe and results usually from aspiration of gastric/oropharyngeal secretions and caused by potentially drug resistant organisms like methicillin resistant staphylococcus aureus (MRSA) and Pseudomonas. The diagnosis of VAP is made by clinical criteria recently revised by National Nosocomial infection Surveillance System (NNIS) for pediatric patients 3. It should be however noted that a "gold standard" for microbiological diagnosis of VAP does not exist. For microbiological diagnosis either bronchoscopic methods like bronchoalveolar lavage, protected specimen brushing (PSB) or non-bronchoscopic methods like quantitative endotracheal aspirate (ETA) is used in most intensive care units (ICUs). In countries especially like India, clinical and radiological criteria in association with semiquantitative ETA are accessible to most ICUs. VAP has been extensively studied in adults but there is great paucity of data of VAP in children especially in neonatal age, so this study was done.
METHODOLOGY
This is a prospective observational study conducted in a NICU of a tertiary care teaching hospital for a period of one year from September 2004 to August 2005 after seeking approval from the institute's Ethics committee. NICU of the hospital was 30 bedded with 11 ventilators at that time. All intubated patients admitted in the NICU during the study period were enrolled in the study consecutively. Neonates requiring MV for less than 48 hours and those who had pneumonia at the time of initiation of MV were excluded from study. The diagnosis of VAP was made on the basis of criteria given by National Nosocomial Infection Surveillance system (1996), the pediatric modification of the original guidelines given by Center for Disease Control and Prevention (CDC) 3. Early onset VAP was defined as which develops within 5 days of MV and Late onset VAP, which develops five or more days after initiation of mechanical ventilation. The protocol that was followed in the NICU was as detailed below:
• All patients were ventilated by orotracheal tube, which was changed only if, blocked or displaced.
• Patients were ventilated in SIMV/CMV/ACV mode using Breathline digivent and Babylog 8000-plus Drager ventilator with heated humidification system.
• One set of disposable ventilation circuit was used for one patient. Open method of suction was used for suctioning of secretions.
• Patients were ventilated in supine position with frequent changing to right lateral and left lateral position and nasogastric tube was put in all patients.
• Patients were placed on Servo controlled warmer with skin temperature set on 37.0 0 C with an audiovisual alarm on ±1 0 C temperature.
• Any hyperthermia (>38 0 C) or hypothermia (<36 0 C) was rechecked by clinical thermometer by axillary method.
• There was no use of H 2 blocker among study cases.
• No prophylactic topical oropharyngeal antibiotics and selective gut decontamination was done in any of the patients.
• Baseline total leukocyte count, differential leukocyte count and chest X ray P-A view were done in all patients at the time of initiation of MV.
• Subsequent blood counts were done on day 3, day on which pneumonia was suspected by the onset of fever, new chest signs, increasing ventilator requirements.
• After Baseline chest X-ray, next chest Xray was done after 48 hours of mechanical ventilation, on suspicion of pneumonia or any other pulmonary complication, 48 hours after pneumonia was detected to check for persistence of infiltrates, otherwise routinely once weekly if no pneumonia was detected.
• Follow up included clinical examination for pneumonia and chest X-ray after one week of extubation.
Collection of endotracheal aspirate
After proper hand washing and wearing sterile gloves before suctioning, the endotracheal secretions were collected by instilling 1-2 ml of sterile normal saline into the endotracheal tube and then collecting it back with the help of sterile mucous trap. CFU/ml of endotracheal aspirate was the cut off between organisms causing VAP and colonization. Blood cultures were collected whenever there was a suspicion of VAP. The site of sample was cleaned with povidone iodine and alcohol and allowed to dry for two minutes. Two ml of blood was added to bile broth and trypticase soya broth (1 ml in each bottle). After overnight incubation at 37 0 C it was inoculated on blood agar and McConkey's agar. The reporting of the X-ray was done by one consultant radiologist of our centre to minimize the interobserver bias.
Statistical Analysis
Data were analyzed using statistical software package, STATA 8.2. Proportions were compared using Chi squire statistics and were supported by 95% Confidence Limits wherever required. Fisher's exact p-value to see the difference between the mean of two different groups if data was normally distributed. If data was not found to be normally distributed, a non-parametric equivalent of two-sample ttest, the Mann Whitney test used to test the level of significance between two values. The difference between any two groups was considered to be significant if p value was < 0.05. The method for multiple regression analysis was 'Enter' method and this analysis was done using Stata 9.2 software, College Station, TX.
RESULTS
Of 248 mechanically ventilated patients, 98 fulfilled the inclusion criteria and formed the subjects. About 10% of these patients were given AMBU bag ventilation for variable periods before being provided with mechanical ventilator. Table 1 shows the demographic profile of the study patients.
Incidence of VAP
VAP developed in 30 of 98 neonates (30.6% VAP rate). Incidence of VAP was 37.2 per thousand days of MV. The mean duration of ventilation before the onset of pneumonia was 5 days. 14 (46.6%) cases developed VAP within 5 days of mechanical ventilation and were classified as early onset VAP. Rest16 (53.3%) cases developed pneumonia >5 days of ventilation and cases categorized under late onset VAP.
Risk factors for VAP
Intubated neonates who developed VAP were compared with those who did not develop VAP with respect to post natal age, birth weight, prematurity (gestational ages < 37 weeks), duration of mechanical ventilation, number of reintubations, length of NICU stay, primary diagnosis of neonate and small for gestational age (SGA). Very low birth weight, prematurity, duration of MV, number of reintubations and length of NICU stay were significantly associated with VAP as observed by bivariate analysis. However, there were statistically no significant difference between the two groups with respect to post natal age (day on which pneumonia developed), sex and SGA. (Table 2) Multiple logistic regression analysis revealed that duration of MV (OR 1.10; 95%CI 1.02, 1.21; P = 0.021) and very low birth weight (birth weight < 1500 gram) (OR 3.88; 95%CI 1.05, 14.34; P = 0.042) were two single independent and statistically significant risk factors for development of VAP. (Table 3) 
Outcome
The mean length of NICU stay was significantly longer in patients with VAP as compared to those with out VAP i.e. 232.7 days Vs 19.7 days (p = 0.028). Mortality rates were higher in patients with VAP (40%) and lower in non-VAP cases (22.06%) (p=0.058). Among the study population of 98 neonates, 27 expired (27.5%). . The quantitative bacteriologic methods have increased the reliability of sputum specimens for the diagnosis of lower respiratory tract infections when compared with conventional qualitative cultures because of more careful collection of sputum and the method of dilution which eliminates contaminating oropharyngeal secretions.
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However, Marquette 14 et al in their study comparing endotracheal aspirate (ETA) cultures with PSB found that the former technique could be used as a reliable alternative to PSB at the cut off value of 10 6 CFU/mL. These findings compare favorably with our study where we had used the semiquantitative cultures of the ETA aspirates at a cut off point of 10 5 CFU/mL. Since the technique of PSB and BAL are not readily available to us in our NICU, the ET aspirate semiquantitative technique can be used as an alternative diagnostic tool for VAP. It may be helpful in differentiating infection from colonization and can thus reduce the overuse of antibiotics in NICU. Moreover, it is a simple, inexpensive and non-invasive technique and suited to the set up where cost becomes a major limiting factor. In our study the mean duration of ventilation before the onset of pneumonia was 5 days. Late onset VAP (> 5 days of MV) was more common than early onset VAP (< 5 days of MV) in the ratio of 53.3 % vs. 46.7 % which was statistically not significant. Very low birth weight (< 1500 grams), prematurity (gestational age < 37 week), duration of mechanical ventilation, number of reintubation and length of NICU stay were significantly associated with VAP in bivariate analysis. Multiple regression analysis revealed that duration of mechanical ventilation (OR 1.10; 95% CI 1.02, 1.21; P = 0.021) and very low birth weight i.e. birth weight < 1500 grams (OR 3.88; 95% CI 1.05, 14.34; P = 0.042) were two single independent and statistically significant risk factors for predicting ventilator associated pneumonia. The study conducted by Yuan 6 et al also showed the same results, according to which the risk factors of neonatal VAP were reintubation (OR 5.3; 95% CI 2.0, 14.0), duration of mechanical ventilation (OR 4.8; 95%CI 2.2, 10.4), treatment with opiates (OR 3.8; 95%CI 1.8, 8.5) and endotracheal suctioning (OR 3.5; 95% CI 1.6, 7.4). Apisarnthanarak et al 4 also found similar results showing high rates of VAP in extremely preterm neonate (EGA < 28 weeks). The incidence rate of VAP were 6.5 per 1000 ventilator days for patients with EGA < 28 weeks and 4 per 1000 ventilator days for EGA > 28 weeks. In their study, they have included those neonates who were having birth weight < 2000 gm and have been given MV for more than 48 hours. In a study conducted by Petdachai et al 5 , stepwise logistic regression analysis identified 3 factors independently associated with VAP: umbilical catheterization (adjusted odds ratio (AOR) 2.5; 95% CI=1.3 to 4.7; P = 0.007), respiratory distress syndrome (AOR 2.0; 95% CI 1.0 to 3.9; P = 0.03) and insertion of orogastric tube (AOR 3.0; 95% CI 1.3 to 7.2; P = 0.01). Infants with VAP had longer duration on ventilator (14.2 days vs 5.9 days; p < 0.001) and longer hospital stay (28.2 days vs 13.8 days; P < 0.001) . As far as etiological organisms are concerned, gram negative predominance was observed as a causative factor of VAP in our study. Earlier neonatal studies 4, 5, 6 reported similar finding. In the present study, most common causative organism was Klebsiella spp. (32. 4 . Therefore, it is unlikely that VAP occurred as a direct consequence of BSI. A randomized controlled trial which was done to test the hypothesis that intubated infants positioned on their sides would be less likely to contract bacterial colonization in their tracheae, compared with those positioned supine, showed that compared with the lateral group, more infants in the supine group experienced increased colony counts or had new organisms in their tracheal aspirates over time (21 vs 8 infants). The most common organisms isolated from tracheal aspirates in both groups were Gram-negative rods 16 . A study was done to compare the airway pressure (NCPAP) treatment (1.8/1000 NCPAP days) rates of nosocomial pneumonia with nasal CPAP verses VAP among VLBW neonates and it showed that the ventilator associated pneumonia (VAP) rate (12.5/1000 ventilator days) seemed significantly higher than the pneumonia rate during NCPAP (p = 0.04) 17 .
Limitation of study
There are several limitations in our study. The NNIS definition of VAP lacks specificity; also there is no current gold standard for defining or diagnosis of VAP. Cordero L et al 18, 19 in their retrospective studies concluded that surveillance diagnosis of VAP in VLBW infants is difficult because current CDC definition are not specific for this population. To improve accuracy, surveillance diagnosis of VAP in special populations such as VLBW infants should be reformulated; meanwhile, infection control practitioners should seek consultation with experienced clinicians for interpretation of data 18 . Because tracheal aspirate was used as a means to identify organisms associated with VAP, we found some of our VAP patients (4 cases) had multiple organisms isolated and some were contaminated. Some of the VAP patients did not have purulent tracheal aspirate with no isolated organism, which suggests that some of these VAP episodes may represent colonization rather than true VAP. Nevertheless, this limitation was minimized because our NICU attending physician reviewed the radiographs of all the patients and radiological and clinical diagnosis was the primary diagnosis of VAP with microbiology as a secondary supportive part of it. Small sample size of this study limits the statistical power to detect other possible independent risk factors for VAP and for mortality of patients. Our data did not include the indication for reintubation which also may be a relevant risk factor for VAP. Because many of the NICU patients had concurrent nosocomial infections during their NICU stay, the attributable morbidity and mortality associated with VAP cannot be determined from our study.
CONCLUSION
The endotracheal aspirate of the patients on ventilator should be sent routinely for culture sensitivity and if the patient develops VAP, antibiotic should be changed as per report. By using aseptic precautions while handling ventilated patients and empirical antibiotics as per the endotracheal aspirate sensitivity pattern of our NICU in the patients who develop nosocomial pneumonia, we may be able to improve the outcome rate of the patients on mechanical ventilation. Additional studies are necessary to develop interventions to prevent neonatal VAP.
